VMP 32879011000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Paliperidone 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes
BNF code 0402020ABAAAGAG
Virtual Therapeutic Moiety Paliperidone
Abbreviated name Paliperidone 263mg/1.315ml prolonged-release inj pf syringes
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.315
Unit dose form units ml
Unit dose unit of measure pre-filled disposable injection
Virtual Product Ingredient
Ingredient Paliperidone palmitate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 426276000
Strength value numerator 200.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspensioninjectionprolonged-release.intramuscular
Dose Form
Formulation Prolonged-release suspension for injection
Drug Route
Route Intramuscular
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Trevicta 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd)
Virtual Medicinal Product Packs
Paliperidone 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection

dm+d data retrieved from TRUD: release NHSBSA_12.0.0_20221205000001, imported on 6th December 2022 at 03:53:42.